Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/24 20:42 | 1/26/24 | LPTX | Health | Drug | Pharmaceutical Preparations | Mirabelli Christopher | MA | DO | CB | M.d | 0 | 0.00 | 0 | 5 | 1 | 420 | D | ||||||||||||||
1/30/24 20:41 | 1/26/24 | LPTX | Health | Drug | Pharmaceutical Preparations | O'Mahony John Mark | MA | O | Chief Ma | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D | ||||||||||||||
1/30/24 20:39 | 1/26/24 | LPTX | Health | Drug | Pharmaceutical Preparations | Sirard Cynthia | MA | O | Chief Me | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D | ||||||||||||||
1/30/24 20:38 | 1/26/24 | LPTX | Health | Drug | Pharmaceutical Preparations | Lawlor Augustine | MA | O | COO | M.d | 0 | 0.00 | 0 | 5 | 1 | 681 | D | ||||||||||||||
1/30/24 20:37 | 1/26/24 | LPTX | Health | Drug | Pharmaceutical Preparations | Onsi Douglas E | MA | DO | CEO,CFO, | M.d | 0 | 0.00 | 0 | 8 | 2 | 488 | D | ||||||||||||||
3/21/23 16:05 | 3/17/23 | LPTX | Health | Drug | Pharmaceutical Preparations | Onsi Douglas E | MA | DO | CEO,CFO, | M.d | 0 | 0.00 | 0 | 661 | 16 | 4,806 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |